Clinical trial

Trazodone in Painful Diabetic Neuropathy

NCT03202979

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-05-16

PhasePHASE2

Study timeline

Study start (actual)2017-05-16Date precision: day

Registry last updated2018-09-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Painful Diabetic Neuropathyunresolved

Interventions

Trazodone 20 mgDRUG

Trazodone 10 mgDRUG

PlaceboDRUG

Sponsors & collaborators

Aziende Chimiche Riunite Angelini Francesco S.p.Alead sponsor

Chiltern International Inc.collaborator

Mapped research locations

WarsawPoland2 BudapestHungary2 KatowicePoland2 PragueCzechia1 LublinPoland1 SzegedHungary1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03202979 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.